Filing Details
- Accession Number:
- 0001181431-13-050406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-24 17:13:51
- Reporting Period:
- 2013-09-20
- Filing Date:
- 2013-09-24
- Accepted Time:
- 2013-09-24 17:13:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Commercial Physical & Biological Research (8731) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1199735 | Sally Crawford | C/O Exact Sciences Corp. 441 Charmany Drive Madison WI 53719 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-20 | 15,000 | $4.99 | 218,866 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-09-20 | 10,000 | $2.24 | 228,866 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-20 | 25,000 | $12.19 | 203,866 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-09-20 | 15,000 | $0.00 | 15,000 | $4.99 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-09-20 | 10,000 | $0.00 | 10,000 | $2.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-07-23 | 2014-07-23 | No | 4 | M | Direct |
| 5,000 | 2006-07-22 | 2015-07-22 | No | 4 | M | Direct |
Footnotes
- These options were issued to Ms. Crawford, who has served as a director of the Company since 1999, as compensation for director service in 2004 and 2005 under the Company's non-employee director compensation policy. The exercise of these options and subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $12.09, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
Billionaire Hedge Funds
